title: Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour.
abstract: BACKGROUND
  Acute early vascular toxicity of chemotherapy for germ cell tumour (GCT) is poorly understood. To explore the pathogenesis of this complication we evaluated laboratory parameters associated with vascular disease.
  
  
  METHODS
  In 33 GCT patients the following parameters were investigated with routine laboratory methods before and after chemotherapy: von Willebrand factor antigen (vWF:AG), collagen binding capacity (vWF:CB), lipoprotein (a), homocysteine, plasminogen activator inhibitor I, total cholesterol, high density lipoprotein, low density lipoprotein, troponine I. Statistical evaluation involved descriptive analysis and the Wilcoxon signed rank test.
  
  
  RESULTS
  Levels of vWF:AG and vWF:CB increased significantly upon therapy (p=0.002). All other parameters remained unchanged. Upon late measurement, vWF:AG and vWF:CB were normalised.
  
  
  CONCLUSIONS
  As von Willebrand factor is released from endothelial cells upon damage, we postulate that early vascular toxicity of chemotherapy is caused by direct damage of the vascular endothelium. Long-term vascular complications of chemotherapy appear to be different, pathogenetically.
authors.affiliation: Klinik für Urologie, Albertinen-Krankenhaus, Suentelstrasse 11a, D-22457 Hamburg, Germany. DieckmannKP@t-online.de
authors.forename: Klaus-Peter
authors.initials: KP
authors.lastname: Dieckmann
authors.forename: Werner Jan
authors.initials: WJ
authors.lastname: Struss
authors.forename: Ulrich
authors.initials: U
authors.lastname: Budde
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002784:Cholesterol / Q000378:metabolism; D002945:Cisplatin / Q000494:pharmacology*; D003094:Collagen / Q000737:chemistry; D004730:Endothelium, Vascular / Q000187:drug effects*; D006801:Humans; D017270:Lipoprotein(a) / Q000737:chemistry; D008297:Male; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy*; D015849:Plasminogen Inactivators / Q000378:metabolism; D013927:Thrombosis / Q000139:chemically induced; D014652:Vascular Diseases / Q000139:chemically induced*; D014841:von Willebrand Factor / Q000096:biosynthesis
chemical_list: D000970:Antineoplastic Agents; D017270:Lipoprotein(a); D015849:Plasminogen Inactivators; D014841:von Willebrand Factor; D003094:Collagen; D002784:Cholesterol; D002945:Cisplatin